A Multicenter, Randomized, Placebo-controlled, Double-blind Phase II Study of KLH-2109 in Patients With Endometriosis(2).
Phase of Trial: Phase II
Latest Information Update: 12 Jul 2014
At a glance
- Drugs KLH 2109 (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 29 May 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 07 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Feb 2012 New trial record